Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.
|
25188863 |
2015 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
To investigate the clinicopathological features of six unusual cases of nodal CD56+ and Epstein-Barr virus (EBV)+ T/natural killer (NK)-cell lymphoma, a putative nodal counterpart of nasal NK/T-cell lymphoma (nodal T/NK-cell lymphoma of nasal type) in comparison with nasal NK/T-cell lymphoma with secondary lymph node involvement (n = 24) and peripheral T-cell lymphoma (PTCL) of cytotoxic molecule (CTM)+ and EBV+ type (n = 21).
|
18370955 |
2008 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
An unusual case of peripheral T-cell lymphoma with CD56 positivity and angiocentric, angiodestructive morphology arising in the ileum.
|
15794680 |
2005 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, there seems to be a useful distinction between the classical NK/T type of nasal lymphoma (CD56+/n-cdk6+/CD44-/TcR-GR-) and PTL (CD56-/n-cdk6-/CD44+/TcR-GR+) involving the nasal region.
|
10879740 |
2000 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Expression of neural cell adhesion molecule (CD56) has been reported to correlate with an increased incidence of central nervous system involvement in peripheral T-cell lymphoma; all their cases were CD56 negative.
|
10976700 |
2000 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Three cases were "peripheral T-cell lymphomas (PTCL), unspecified" with positivity for CD3, CD8, and betaF1 and negativity for CD56.
|
10571346 |
1999 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We also studied the expression of these molecules in 92 other cases of T-cell and natural killer (NK) cell neoplasms; 18 anaplastic large cell lymphomas (ALCLs); 63 CD4+ PTCLs; 10 CD56+ nasal lymphomas; and 1 NK-cell leukemia.
|
9578080 |
1998 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Altogether these findings show that CD5-CD56+ so-called "TCR silent PTCL" bear the immunophenotype and immunogenotype of normal NK cells and display peculiar clinical features distinct from true PTCL.
|
8608237 |
1996 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Among 15 cases of CD56-negative non-nasal peripheral T-cell lymphoma studied for comparison, six were CD3-negative, among which three showed EBER positivity.
|
7520016 |
1994 |
Peripheral T-Cell Lymphoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Six cases displayed a CD3-, TCR alpha beta-, TCR gamma delta-, CD2+, CD7+, CD5-, CD4-, CD8-, CD56+ phenotype, suggesting that these tumors may be peripheral T-cell lymphomas (PTCL) with extensive loss of T-cell antigens and expression of the NK-cell (CD56) antigen or, alternatively, NK-cell neoplasias.
|
8387835 |
1993 |
Peripheral T-Cell Lymphoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
A distinct subset of patients with peripheral T-cell lymphoma (PTCL) is described which reacts with Leu-19 (CD56), an antibody that has been shown to identify the neural cell adhesion molecule (NCAM).
|
1373974 |
1992 |